Home » Clinical Times » Eye, Ear, Nose & Throat

Eye, Ear, Nose & Throat

Screening for dysphagia can aid return to oral feeding

Nurse screening for dysphagia in postextubation critically ill patients can increase a successful return to oral feeding at ICU discharge and decrease the chances of patients developing postextubation pneumonia, new research suggests.

One-in-10 US adults reports tinnitus

Nearly one-in-10 US adults has tinnitus, and according to a new study published online by JAMA Otolaryngology-Head & Neck Surgery, durations of occupational and leisure time noise exposures are correlated with rates of the condition and are likely targetable risk factors.

High-priced drugs for DMO questioned

The anti-vascular endothelial growth factor drugs ranibizumab and aflibercept, used to treat vision loss from diabetic macular oedema (DMO), and approximately 20 to 30 times more expensive than bevacizumab, are not cost-effective for treatment of DMO compared to bevacizumab, unless their prices decrease substantially, according to a study published online by JAMA Ophthalmology

The diagnosis, treatment and management of cataracts

Mr Arthur Cummings, Medical Director at the Wellington Eye Clinic and Head of the Department of Ophthalmology at the Beacon Hospital, explores why cataract surgery is enjoying an all-time high safety and success profile, and explains how advances in treatment has allowed patients to seek surgery earlier.

Hearing loss in older patients is linked with increased risk of death

Moderate or more severe hearing impairment in a sample of adults 70 years or older was associated with an increased risk of death, with greater impairment increasing the risk, compared to older adults without hearing impairment, according to a study published online by JAMA Otolaryngology-Head & Neck Surgery.

Breaking through the silence

Suitable children with profound nerve hearing loss should ideally receive cochlear implants as close to age 12 months as possible.

Screening round analysis this year

Early detection of diabetic retinopathy is key — as the condition can lead to vision loss and blindness that is preventable, Gary Culliton reports in his latest Clinical Update.